Megan Hall
👤 SpeakerVoice Profile Active
This person's voice can be automatically recognized across podcast episodes using AI voice matching.
Appearances Over Time
Podcast Appearances
Screening is common in the U.S.
for a handful of cancers like breast, colon, and cervical.
But recent research in the Journal of Clinical Oncology on patients in the U.K.
showed blood tests that can detect cancer markers can help catch disease earlier.
Megan Hall heads medical affairs for Grail.
the company that makes the test used in the study.
She says such tests, currently under regulatory review, could help improve survival rates.
Screening is common in the U.S.
for a handful of cancers like breast, colon, and cervical.
But recent research in the Journal of Clinical Oncology on patients in the U.K.
showed blood tests that can detect cancer markers can help catch disease earlier.
Megan Hall heads medical affairs for Grail, the company that makes the test used in the study.
She says such tests, currently under regulatory review, could help improve survival rates.
Screening is common in the U.S.
for a handful of cancers like breast, colon, and cervical.
But recent research in the Journal of Clinical Oncology on patients in the U.K.,
showed blood tests that can detect cancer markers can help catch disease earlier.
Megan Hall heads medical affairs for Grail, the company that makes the test used in the study.
She says such tests currently under regulatory review could help improve survival rates.